Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02979353 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy
A NA study of Polypharmacy and Care Transitions, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 372
- Enrollment target
- 1
- Study location
NCT02979353 is a NA study of Polypharmacy and Care Transitions that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 372 participants, below the 1,555-participant average among 8 other Polypharmacy trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02979353, a NA study of Polypharmacy and Care Transitions, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 372 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized, controlled trial will evaluate the effects of an intervention to reduce exposure to medications among hospitalized older adults discharged to skilled nursing facilities (SNFs). The goal of the intervention is to safely deprescribe medications, as defined by dose reductions and stopped medications, based on a combination of clinical criteria and patient preferences. The investigators will evaluate the effects of the intervention on the total number of medications prescribed to patients at hospital and SNF discharge and at home 90-days after SNF discharge along with the prevalence of eight geriatric syndromes, medication adherence, and health status.
Conditions Studied
Interventions
- BEHAVIORAL Shed-Meds: A Patient-Centered Deprescribing Intervention
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 372 participants |
| Start Date | 2017-03-06 |
| Est. Completion | 2021-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02979353
The ClinicalTrials.gov registry entry for NCT02979353 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 372 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,555-participant average among 8 other Polypharmacy trials with a reported enrollment target (76% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Polypharmacy appearing as the primary indexed condition, and to 1 intervention - of which Shed-Meds: A Patient-Centered Deprescribing Intervention is the first listed.
NCT02979353 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT02979353 about?
NCT02979353 is a clinical study titled "A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy". This randomized, controlled trial will evaluate the effects of an intervention to reduce exposure to medications among hospitalized older adults discharged to skilled nursing facilities (SNFs). The goal of the intervention is to safely deprescribe medications, as defined by dose reductions and stopp...
What is the current status of trial NCT02979353?
This trial is currently completed. It is a NA study. The enrollment target is 372 participants. The study started on 2017-03-06. Estimated completion is 2021-05-01.
What conditions does trial NCT02979353 study?
This clinical trial studies the following conditions: Polypharmacy, Care Transitions, Geriatric Syndromes.
What interventions are being tested in trial NCT02979353?
The interventions under investigation include: Shed-Meds: A Patient-Centered Deprescribing Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02979353?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02979353 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polypharmacy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Medication Management in World Trade Center Responders
RECRUITING · NA
-
Effectiveness of PGx Testing
ACTIVE NOT RECRUITING · NA
-
Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial
ACTIVE NOT RECRUITING · NA
-
Preemptive Pharmacogenomics Testing Among Geriatric Patients
ACTIVE NOT RECRUITING · NA
-
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
ACTIVE NOT RECRUITING · NA
-
Tailored Medication Management Intervention
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.